Programmed death ligand 1 (PD-L1) is typically expressed on tumor cells and immune cells such as macrophages and dendritic cells, and the interaction between PD-L1 and its receptor, programmed cell death-1 (PD-1), on T cells inhibits the tumor-killing activity of these cells1–3. This evidence concerns the gene CD274 and neoplasm.